ym 872 has been researched along with nebivolol in 1 studies
| Studies (ym 872) | Trials (ym 872) | Recent Studies (post-2010) (ym 872) | Studies (nebivolol) | Trials (nebivolol) | Recent Studies (post-2010) (nebivolol) |
|---|---|---|---|---|---|
| 41 | 0 | 5 | 6 | 0 | 3 |
| Protein | Taxonomy | ym 872 (IC50) | nebivolol (IC50) |
|---|---|---|---|
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 4.3118 | |
| Sodium channel protein type 5 subunit alpha | Homo sapiens (human) | 7.1264 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
1 other study(ies) available for ym 872 and nebivolol
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |